# Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity

> **NCT00067821** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 79 (actual)

## Conditions studied

- Brain Tumors

## Interventions

- **DRUG:** 2-Flourodeoxyglucose

## Key facts

- **NCT ID:** NCT00067821
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-11
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067821, "Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00067821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*